Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience

BACKGROUND: The immunomodulator mifamurtide plus a chemotherapy regimen has been shown to significantly improve the outcome in non-metastatic osteosarcoma patients. We report the results of the addition of mifamurtide to chemotherapy in newly diagnosed patients with osteosarcoma. METHODS: A total of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Asian Pac J Cancer Prev
Hoofdauteurs: Taçyıldız, Nurdan, Ünal, Emel, Dinçaslan, Handan, Çakmak, H Mine, Köse, Kenan, Tanyıldız, Gülşah, Kartal, Ömer
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: West Asia Organization for Cancer Prevention 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7437342/
https://ncbi.nlm.nih.gov/pubmed/32212798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.3.715
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items